Health Trials

Adamantinomatous Craniopharyngioma

2

Review clinical trials related to Adamantinomatous Craniopharyngioma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.

Participants needed: 595
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Parabilis Medicines, Inc.Updated: May 28, 2026Locations: 33
Eligibility criteria

Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. [+16]

Known history of bone metastasis. Bone metastasis are allowed for patients with... [+6]

Read more
Status: Recruiting

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) Juvenile Idiopathic Arthritis. In this Phase II, the drug will be used to treat pediatric patients diagnosed with recurrent Adamantinomatous Craniopharyngioma including patients who have undergone surgery and/or radiation therapy.

Participants needed: 30
Trial details
Phase: Phase 2Age: 1-39Biological sex: AllType: InterventionalSponsor: Nationwide Children's HospitalUpdated: Apr 23, 2026Locations: 14
Eligibility criteria

Age: Patients must be ≥ 12 months and ≤ 39 years of age at the time of study enr... [+24]

Pregnancy or Breast-Feeding: Pregnant or breast-feeding women will not be entere... [+14]

Read more